GlassScriptPhysician profile
Gregory S Mcnabb
NPI 1871679753
$1,991.98
in general payments reported to CMS, 2019-2025
23 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $27.99 · 2021: $35.77 · 2022: $775 · 2023: $277 · 2024: $412 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $751.05 | 2022-2025 | Inspire |
| Glaxosmithkline, LLC. | $368.97 | 2022-2025 | Nucala |
| Genzyme Corporation | $187.03 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $141.73 | 2019-2023 | Dupixent |
| Aerin Medical INC. | $100.87 | 2024-2025 | |
| Intersect Ent, INC. | $71.30 | 2019-2020 | |
| Teleflex LLC | $52.04 | 2025 | Urolift |
| Acclarent, INC | $37.43 | 2021-2022 | |
| Smith+Nephew, INC. | $34.65 | 2022 | |
| Medtronic USA, INC. | $26.38 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.41 | 2023 | Verquvo, Belsomra |
| Arbor Pharmaceuticals, INC. | $22.28 | 2019 | |
| 180 Medical, INC. | $20.21 | 2024 | |
| Integra Lifesciences Corporation | $19.31 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Optinose US, INC. | $16.95 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $16.21 | 2025 | Arista |
| Tricoast Surgical Solutions LLC | $16.19 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.13 | 2025 | Jardiance |
| Medtronic, INC. | $15.31 | 2022 | |
| Dexcom, INC. | $14.07 | 2025 | Dexcom G6 Transmitter |
| Stryker Corporation | $13.94 | 2025 | Audion Et Dilation System |
| Novo Nordisk INC | $13.28 | 2024 | |
| Kaleo, INC. | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Mcnabb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.